| Dr Juan Manuel Corchado, MD | |
|
Carr 494 Km 1 He 1, Bo Arenales Altos, Isabela, PR 00662 | |
| (787) 872-6281 | |
| Not Available |
| Full Name | Dr Juan Manuel Corchado |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | Carr 494 Km 1 He 1, Isabela, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043665631 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 19667 (Puerto Rico) | Primary |
| Entity Name | Departamento De Salud Oficial |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770703845 PECOS PAC ID: 9537170162 Enrollment ID: O20140417001278 |
News Archive
XOMA Ltd., a leader in the discovery and development of antibody therapeutics, announced results demonstrating that a murine equivalent of XOMA 052, its novel, high-affinity antibody to interleukin-1 beta (IL-1 beta), significantly reduced adverse consequences that usually lead to the development of congestive heart failure in a mouse model of acute myocardial infarction (heart attack).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc..
NovaMed, Inc., a leading operator of ambulatory surgery centers in partnership with physicians, today announced results for the second quarter ended June 30, 2010. Total net revenue was $38,164,000 compared to $38,879,000 in the prior year second quarter. Same-facility net revenue declined 1% for the quarter. Net income from continuing operations attributable to NovaMed in the second quarter of 2010 was $1,805,000, or $0.23 per diluted share, compared to $2,290,000, or $0.30 per diluted share, in the prior year second quarter.
An estimated one in 20 kids suffer from breath-holding spells, which come when they are upset, in pain or surprised. In some cases, the children twitch and jerk around involuntarily, as if they are having a seizure. Their faces sometimes turn blue or pale and they often faint.
CANCER RESEARCH UK scientists have shown how bowel cancer can become aggressive, according to research published in Nature Genetics.
› Verified 8 days ago
| Entity Name | Community Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427609171 PECOS PAC ID: 1355776303 Enrollment ID: O20200121001343 |
News Archive
XOMA Ltd., a leader in the discovery and development of antibody therapeutics, announced results demonstrating that a murine equivalent of XOMA 052, its novel, high-affinity antibody to interleukin-1 beta (IL-1 beta), significantly reduced adverse consequences that usually lead to the development of congestive heart failure in a mouse model of acute myocardial infarction (heart attack).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc..
NovaMed, Inc., a leading operator of ambulatory surgery centers in partnership with physicians, today announced results for the second quarter ended June 30, 2010. Total net revenue was $38,164,000 compared to $38,879,000 in the prior year second quarter. Same-facility net revenue declined 1% for the quarter. Net income from continuing operations attributable to NovaMed in the second quarter of 2010 was $1,805,000, or $0.23 per diluted share, compared to $2,290,000, or $0.30 per diluted share, in the prior year second quarter.
An estimated one in 20 kids suffer from breath-holding spells, which come when they are upset, in pain or surprised. In some cases, the children twitch and jerk around involuntarily, as if they are having a seizure. Their faces sometimes turn blue or pale and they often faint.
CANCER RESEARCH UK scientists have shown how bowel cancer can become aggressive, according to research published in Nature Genetics.
› Verified 8 days ago
| Entity Name | Nova Healthcare Services Crl |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760173983 PECOS PAC ID: 8527413319 Enrollment ID: O20231013003198 |
News Archive
XOMA Ltd., a leader in the discovery and development of antibody therapeutics, announced results demonstrating that a murine equivalent of XOMA 052, its novel, high-affinity antibody to interleukin-1 beta (IL-1 beta), significantly reduced adverse consequences that usually lead to the development of congestive heart failure in a mouse model of acute myocardial infarction (heart attack).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc..
NovaMed, Inc., a leading operator of ambulatory surgery centers in partnership with physicians, today announced results for the second quarter ended June 30, 2010. Total net revenue was $38,164,000 compared to $38,879,000 in the prior year second quarter. Same-facility net revenue declined 1% for the quarter. Net income from continuing operations attributable to NovaMed in the second quarter of 2010 was $1,805,000, or $0.23 per diluted share, compared to $2,290,000, or $0.30 per diluted share, in the prior year second quarter.
An estimated one in 20 kids suffer from breath-holding spells, which come when they are upset, in pain or surprised. In some cases, the children twitch and jerk around involuntarily, as if they are having a seizure. Their faces sometimes turn blue or pale and they often faint.
CANCER RESEARCH UK scientists have shown how bowel cancer can become aggressive, according to research published in Nature Genetics.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Juan Manuel Corchado, MD Po Box 662, Isabela, PR 00662-0662 Ph: (787) 872-6281 | Dr Juan Manuel Corchado, MD Carr 494 Km 1 He 1, Bo Arenales Altos, Isabela, PR 00662 Ph: (787) 872-6281 |
News Archive
XOMA Ltd., a leader in the discovery and development of antibody therapeutics, announced results demonstrating that a murine equivalent of XOMA 052, its novel, high-affinity antibody to interleukin-1 beta (IL-1 beta), significantly reduced adverse consequences that usually lead to the development of congestive heart failure in a mouse model of acute myocardial infarction (heart attack).
Hospira, Inc., a global specialty pharmaceutical and medication delivery company, today announced the successful completion of the tender offer by Discus Acquisition Corporation, a wholly owned Hospira subsidiary, to purchase all outstanding shares of the common stock of Javelin Pharmaceuticals, Inc..
NovaMed, Inc., a leading operator of ambulatory surgery centers in partnership with physicians, today announced results for the second quarter ended June 30, 2010. Total net revenue was $38,164,000 compared to $38,879,000 in the prior year second quarter. Same-facility net revenue declined 1% for the quarter. Net income from continuing operations attributable to NovaMed in the second quarter of 2010 was $1,805,000, or $0.23 per diluted share, compared to $2,290,000, or $0.30 per diluted share, in the prior year second quarter.
An estimated one in 20 kids suffer from breath-holding spells, which come when they are upset, in pain or surprised. In some cases, the children twitch and jerk around involuntarily, as if they are having a seizure. Their faces sometimes turn blue or pale and they often faint.
CANCER RESEARCH UK scientists have shown how bowel cancer can become aggressive, according to research published in Nature Genetics.
› Verified 8 days ago
Dr. Huber A Tavarez Gonzalez, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Carr 474 Km 2.2, Bo Cotto, Isabela, PR 00662 Phone: 787-830-7472 | |
Dr. Juan Carlos Fantauzzi, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Carr 112 Int, Bo Bejucos Sect Florida, Isabela, PR 00662 Phone: 787-234-3729 | |
Dr. Isennia Marin, MD General Practice Medicare: Medicare Enrolled Practice Location: 414 Calle Copasu, Llanos De Isabela, Isabela, PR 00662 Phone: 787-207-6394 | |
Dr. Adrian Girald-rosa, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: Carr 2 Bo Mora Km 111.3, Isabela, PR 00662 Phone: 787-830-7737 Fax: 787-830-7839 | |
Dr. Hector Noel Vega Vega, General Practice Medicare: Accepting Medicare Assignments Practice Location: Carr. 2 Int Km 112.6, Bo. Guerrero Sec. La Curva, Isabela, PR 00662 Phone: 787-872-2850 Fax: 787-872-2850 | |
Dr. David Hormoz Kalantar, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 7468 Calle Agustin Ramos Calero, Isabela, PR 00662 Phone: 787-830-6210 Fax: 787-830-6215 |